Antiribosomal P antibodies in patients with lupus glomerulonephritis
Monova, D.; Argirova, T.; Monov, S.
Clinical Nephrology 55(5): 425-426
2001
ISSN/ISBN: 0301-0430 PMID: 11393393 Document Number: 537411
Document emailed within 1 workday
Related Documents
Yoshio, T.; Hirata, D.; Onda, K.; Nara, H.; Minota, S. 2005: Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus Journal of Rheumatology 32(1): 34-39Yoshio, T.; Masuyama, J.; Ikeda, M.; Tamai, K.; Hachiya, T.; Emori, T.; Mimori, A.; Takeda, A.; Minota, S.; Kano, S. 1995: Quantification of antiribosomal P0 protein antibodies by ELISA with recombinant P0 fusion protein and their association with central nervous system disease in systemic lupus erythematosus Journal of Rheumatology 22(9): 1681-1687
Nakabayashi, K.; Yoshida, M.; Nagasawa, T. 1981: Serial changes of lymphocyte subpopulations, anti-T cell antibodies, and circulating immune complexes in patients with lupus nephritis, nephrotic syndrome and poststreptococcal acute glomerulonephritis Nihon Jinzo Gakkai Shi 23(3): 253-263
Tareeva, I.E.; Filimonova, R.G.; Maksudova, M.K.; Khaletskaia, E.V.; Fadeeva, L.L. 1978: Antibodies to viral antigens in chronic glomerulonephritis and lupus nephritis Klinicheskaia Meditsina 56(2): 70-73
Adu, D.; Williams, D.G.; Taube, D.; Vilches, A.R.; Turner, D.R.; Cameron, J.S.; Ogg, C.S. 1983: Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis Quarterly Journal of Medicine 52(208): 471-487
Bhandari, B.; Pal, A.; Maulik, S.; Chakraborti, S. 2012: Lupus glomerulonephritis: a clinicopathological correlation of 93 patients of systemic lupus erythematosus for a follow-up period of three years Journal of the Indian Medical Association 110(10): 710-714
Horbach, D.A.; van Oort, E.; Donders, R.C.; Derksen, R.H.; de Groot, P.G. 1996: Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies Thrombosis and Haemostasis 76(6): 916-924
Alarcon-Segovia, D.; Mestanza, M.; Cabiedes, J.; Cabral, A.R. 1997: The antiphospholipid/cofactor syndromes. II. a variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein i but no antibodies detectable in standard antiphospholipid assays Journal of Rheumatology 24(8): 1545-1551
Altiparmak, M.R.; Pamuk, O.N.; Pamuk, G.E.; Mert, A.; Ataman, R.; Serdengeçti, K. 2001: Prevalence of serum antibodies to hepatitis B and C viruses in patients with primary glomerulonephritis Journal of Nephrology 14(5): 388-391
Acosta-Mérida, A.; Isenberg, D.A. 2013: Antinuclear antibodies seroconversion in 100 patients with lupus Clinical and Experimental Rheumatology 31(4): 656
Leaños Miranda, L.; Bustos López, H.H.; Fraga Mouret, A.; Blanco Favela, F.; Dalila Pascoe Lira, M.E.; Dalila Pascoe Lira, C. 1998: Antibodies against prolactin in patients with systemic lupus erythematosus and hyperprolactinemia Ginecologia y Obstetricia de Mexico 66: 179-186
Johns, A.S.; Chamley, L.; Ockelford, P.A.; Pattison, N.S.; McKay, E.J.; Corkill, M.; Hart, H. 1994: Comparison of tests for the lupus anticoagulant and antiphospholipid antibodies in systemic lupus erythematosus Clinical and Experimental Rheumatology 12(5): 523-526
Mach, P.S.; Kharouby, M.; Lutcher, F.; Olivier, J.L.; Bazely, N.; Dougados, M.; Amor, B. 1984: The in vitro production of anti-nuclear antibodies by human peripheral blood mononuclear cells. Demonstration of T cell requirement and soluble inducing factor(s) for anti-nuclear antibodies triggering in patients with systemic lupus erythematosus Clinical and Experimental Immunology 57(3): 535-540
Abdel Gawad, E.R.; Mansour, A.I.; Abdel Aziz, Y.A.; Soliman, A.F.; Fawzy, R.M. 2014: Role of anti-nucleosome antibodies in the diagnosis of systemic lupus erythematosus and as a marker for lupus nephropathy Egyptian Journal of Immunology 21(1): 57-65
Bardach, H. 1982: ANF-negative subacute cutaneous lupus erythematosus with anti-Ro antibodies. a new subset of lupus with characteristic skin manifestations Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 33(10): 537-541
Levy, R.A.; Gharavi, A.E.; Sammaritano, L.R.; Habina, L.; Qamar, T.; Lockshin, M.D. 1990: Characteristics of IgG antiphospholipid antibodies in patients with systemic lupus erythematosus and syphilis Journal of Rheumatology 17(8): 1036-1041
Nakano, M.; Ohuchi, Y.; Hasegawa, H.; Kuroda, T.; Ito, S.; Gejyo, F. 2000: Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus Journal of Rheumatology 27(6): 1403-1407
Falcao, C.A.; Alves, I.C.; Chahade, W.H.; Duarte, A.L.B.P.; Lucena-Silva, N. 2002: Echocardiographic abnormalities and antiphospholipid antibodies in patients with systemic lupus erythematosus Arquivos Brasileiros de Cardiologia 79(3): 285-291
D'Cruz, D.P.; Mellor-Pita, S.; Joven, B.; Sanna, G.; Allanson, J.; Taylor, J.; Khamashta, M.A.; Hughes, G.R.V. 2004: Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies Journal of Rheumatology 31(2): 280-285
Mackworth-Young, C.; Chan, J.; Harris, N.; Walport, M.; Bernstein, R.; Batchelor, R.; Hughes, G.; Gharavi, A. 1987: High incidence of anticardiolipin antibodies in relatives of patients with systemic lupus erythematosus Journal of Rheumatology 14(4): 723-726